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Background: In children with chronic pain, interdisciplinary outpatient and intensive inpatient treatment has been
shown to improve pain intensity and disability. However, there are few systematic comparisons of outcomes of the
two treatments. The present naturalistic study aimed to compare the clinical presentation and achieved changes at
return in three outcome domains (pain intensity, disability, school absence) between a) outpatients vs. inpatients
and b) patients who declined intensive inpatient treatment and completed outpatient treatment instead (decliners)
vs. those who completed inpatient treatment (completers).
Methods: The study compared treatment outcomes between n = 992 outpatients vs. n = 320 inpatients (Analysis A)
who were treated at a tertiary treatment centre and returned for a return visit within a one-year interval. In Analysis B,
treatment outcomes were compared between n = 67 decliners vs. n = 309 completers of inpatient treatment. The three
outcome domains were compared by calculating standardized change scores and clinically significant changes.
Results: In analysis A, outpatients and inpatients reported comparably low levels of pain intensity (NRS 0–10; mean = 4,
SD= 2.7) and disability (Paediatric Pain Disability Index (PPDI: 12–60; mean = 24; SD= 10) at the return visit. Compared to
outpatients, more inpatients achieved clinically significant changes in pain intensity (52% vs. 45%) and disability (46% vs.
31%). There were also significantly greater changes in disability in the inpatient group (change score outpatients = 1.0;
change score inpatients = 1.4; F(1,1138) = 12.6, p = .011). School absence was substantially reduced, with approximately 80% in
each group attending school regularly. Analysis B showed that even though inpatient decliners achieved improvements
in the outcome domains, they reported greater disability at the return visit (PPDI mean decliners = 27, SD = 9.9; PPDI mean
completers = 24, SD = 10) because they had achieved fewer changes in disability (change score decliners = 0.9; change score
completers = 1.4; F(1.334) = 5.7, p = .017). In addition, less decliners than completers achieved clinically significant changes in
disability (25% vs. 47%).
Conclusions: Inpatient and outpatient treatments are able to elicit substantial changes in pain intensity, disability and
school absence. The results highlight the necessity of intensive inpatient pain treatment for highly affected children, as
children who declined inpatient treatment and were treated as outpatients did less well.
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Highly disabling chronic pain is a frequent complaint in
children, with consistent prevalence estimates of ap-
proximately five percent in Western countries [1]. This
condition can cause severe impairments for the child
and suffering for his/her family [2]. Costs are also exor-
bitant in paediatric chronic pain [3]. These children ac-
cess a variety of healthcare services, including primary
care physicians, radiological examinations and visits to
the emergency department [3].
It is widely accepted that the treatment of children with a
severe chronic pain problem requires a specialised interdis-
ciplinary approach and the stratification of treatment
intensity, depending on the child’s status [2], as either an
interdisciplinary outpatient treatment [4,5] or a more inten-
sive interdisciplinary pain treatment provided in an inpatient
or day-hospital setting [6-8]. Children referred to outpatient
treatment are thought to be able to achieve the requested
changes with a less intense therapeutic dose [4]. Typical cri-
teria for the recommendation of intensive interdisciplinary
pain treatment are the child’s pain severity, degree of disabil-
ity, school absences, and failure to progress under less inten-
sive treatments [8,9]. Systematic studies into the validation
of criteria for treatment assignment are lacking [10], and it
is primarily up to the clinicians’ judgement whether children
are assigned to one form of treatment or the other.
Uncontrolled and controlled studies have shown that
children are able to improve significantly and in a long-
term manner when they obtain one of the two treat-
ments (outpatient or intensive interdisciplinary pain
treatment) [4-6,8,11]. Hechler et al. [4] showed that at a
12-month follow-up, almost 70% of the children who
obtained an interdisciplinary outpatient treatment were
able to attend school regularly. Pain intensity, disability
and inappropriate coping strategies were also signifi-
cantly reduced. Similarly, Logan et al. [8] found clinical
and statistical improvements at a median of 10 months
of follow-up in pain intensity, disability, physical func-
tioning, medication use and emotional functioning in a
study of 56 children obtaining intensive interdisciplinary
pain treatment. This finding has also been confirmed
within a randomised-controlled trial [12] in which
children with chronic pain were assigned to either inten-
sive interdisciplinary pain treatment or to a waiting-list
control group. The results at immediate follow-up
showed that approximately 60% of the intervention
group had a clinical improvement, compared to only
14% of the waiting-list control group.
The two forms of treatment, however, have rarely been
compared systematically in terms of their ability to decrease
pain-related symptoms. Simons et al. [13] compared im-
mediate outcomes of 50 children enrolled in intensive
interdisciplinary pain treatment to 50 children who pur-
sued outpatient multidisciplinary treatment matched forgender, pain diagnosis and level of functional disability.
In line with their hypotheses, children enrolled in the
intensive interdisciplinary pain treatment had signifi-
cantly larger improvements in functional disability, and
pain-related fear. While this study provides initial evi-
dence for greater immediate improvements following
intensive interdisciplinary pain treatment, several ques-
tions remain unanswered: First, differences in long-term
outcome between the two treatments have not yet been
investigated. Second, Simons et al. [13] lack a compari-
son of self-reported pain intensity, one of the core out-
come domains according to clinical recommendations
[14]. Third, while the authors control for initial differ-
ences in the clinical presentation, little is known on
treatment outcomes of children with similar clinical
presentation enrolled to intensive interdisciplinary pain
treatment but who decline the recommendation of the
pain team and pursue outpatient multidisciplinary pain
treatment, instead.
The present naturalistic practice-based study had two
objectives. The first objective was to compare the char-
acteristics and changes in outcome domains (pain inten-
sity, disability, school absences) between children who
received outpatient treatment (low end of treatment in-
tensity) or intensive interdisciplinary pain treatment
(high end of treatment intensity) at the time point when
they returned to the treatment centre within a one-year
interval. Based on previous studies, we expected to find
a similar improvement status at the time point of return
in both groups. However, the two groups were expected
to differ in the achieved changes, with inpatients achiev-
ing greater changes than outpatients due to the greater
treatment intensity. The second objective was to com-
pare outcomes between two groups of children who
were recommended intensive interdisciplinary pain
treatment by the pain team: a group who declined inten-
sive interdisciplinary pain treatment but completed out-
patient treatment instead (decliners) and a group who
completed intensive interdisciplinary pain treatment
(completers). This approach enables a comparison of
treatment outcomes of two comparable study popula-
tions who share similar characteristics but who pursue
different treatment pathways.




The sample consisted of consecutive new children with
chronic pain presenting at the German Paediatric Pain
Centre from July 2005 to June 2010 who were treated as
either outpatients or inpatients at the treatment centre
(see Figure 1) and returned for a return visit within a
one-year period. Detailed characteristics of these
Figure 1 Study flowchart and depiction of the two analyses of the study.
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criteria were the following: pain treatment on other
wards of the Children’s and Adolescents’ Hospital
Datteln (e.g., on the gastroenterology ward) prior to the
initial session or palliative diseases. Children with the
latter were referred to the paediatric palliative service
affiliated with the German Paediatric Pain Centre.
Ethics
The present study was approved by the Ethics Committee
of the Children’s Hospital in Datteln, Germany. All chil-
dren and their parents provided written informed consent
for data collection.
General procedure at the German Paediatric Pain Centre
The German Paediatric Pain Centre offers a multimodal
and interdisciplinary treatment within a stratified andstepped-care approach, consisting of outpatient or in-
patient treatment. A paediatrician, a clinical child psych-
ologist and a paediatric nurse evaluate the existing
diagnostic information prior to the initial session and
conduct the initial family session together. Each new re-
ferral is given an interdisciplinary 1.5-hour evaluation.
The key goals of this evaluation are different dependent
on the child’s clinical presentation.Evaluation of the child’s clinical presentation as a core
determinant for treatment allocation
The child’s clinical presentation was evaluated via stan-
dardised diagnostic tools such as the German Pain
Questionnaire for Children and Adolescents (DSF-KJ)
[15] and confirmed during the initial session. Referral to
intensive interdisciplinary pain treatment rather than
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[9,12], of which the child had to fulfil at least three:
1. Severe pain-related disability assessed via the validated
Pain-Disability Index (PPDI) [16] as scores > =36;
2. long pain duration of more than 6 months,
3. high average pain intensity (greater 6 on the NRS),
4. additional pain peaks (defined as pain intensity of 8
and above on the NRS),
5. regular school absence of at least 5 days within the
preceding four weeks.
Treatment at the German Paediatric Pain Centre
Outpatient treatment
This treatment comprises of an à priori evaluation of previ-
ous assessments and treatments of the child’s pain problem
by the paediatrician (3–4 hours), the initial 1.5-hour session
including different modules tailored to the particular needs
of the individual patient, and a treatment plan comprising
medical, and psychological treatment recommendations.
The key goals of the session are to identify the nature
of the chronic pain experience, careful evaluation of
present diagnostic findings, to educate the child and his
or her parents on the biopsychosocial model of chronic
pain, to provide strategies for pain relief, such as an
adaptation of pain medication when necessary (67% were
recommended pain medication during the initial ses-
sion), teaching use of distraction techniques, change in
parental focus on the child’s pain and strategies to attend
school despite pain. These strategies and recommenda-
tions are summarised in the doctor’s letter, which is sent
to the family and the primary paediatrician.
A follow-up appointment is scheduled for three months
following the initial visit, but the children and their fam-
ilies are invited to return to the treatment centre when-
ever they feel that this might be necessary [4].
Intensive interdisciplinary pain treatment
For children with extremely high pain-related impairment
(see criteria for referral), an intensive three-week multimodal
inpatient program is recommended during the initial session
[6,17]. The key goals of the initial session are to enhance
motivation for intensive interdisciplinary pain treatment by
providing detailed information on the nature of the chronic
pain condition, on the treatment program and on reasons
for the intensive pain treatment. The session ends with a
brief tour on the ward. The average waiting time to the in-
patient unit is 3 to 6 weeks without any additional contact
with the pain team in between [12].
An interdisciplinary team (paediatricians, clinical child
psychologists, nursing and educational team (NET),
pediatric psychiatrists, physiotherapists, art therapist, music
therapist and social workers [9]) runs the inpatient program
which consists of six modules: 1) information on thebiopsychosocial concept of chronic pain and realistic goal
attainment; 2) acquisition of pain-coping strategies, 3)
treatment of related problems with school, peers or family;
4) teaching adequate parenting behaviour and family ther-
apy; 5) optional interventions (pharmacological treatment
(recommended to 30.6% (n = 98) following treatment),
physiotherapy (recommended to 2.2% (n = 7) following
treatment)). Pharmacological treatment is limited to pain
due to inflammation or physical disease proven to be re-
sponsive to analgesics. Physiotherapy is used whenever ad-
vanced chronicity along with pronounced avoidance
behaviour results in impaired functioning or impaired
movement [9]. Physiotherapy is designed as an active ther-
apy during which physical activity and active coping are
enhanced. 6) Relapse prevention. Parents are actively en-
gaged in the treatment as part of weekly family sessions
and coaching sessions, during which the parents are
taught to actively support their child and his or her en-
gagement in healthy daily activities. Furthermore, reinte-
gration into the child’s daily life is initiated from the
second week onwards, which includes home visits and
trips to their home school on one appointed day. A
follow-up appointment is scheduled for three months fol-
lowing discharge, but the children and their families are
invited to return to the treatment centre whenever they
feel that this might be necessary (for a detailed description
of the program, see [9]).
Study procedure
All children eligible for the present study obtained the ini-
tial evaluation conducted by the interdisciplinary pain team.
Following this, outpatients had no further contact with the
pain team before the return visit. Inpatients were referred
to the inpatient program with an average waiting time of 3
to 6 weeks. Inpatient treatment lasted for 3 weeks. For the
present study, we assessed outcomes of the child at the
time point of the first return to the treatment centre within
a 12-months-period. The one-year period was chosen based
on clinical experience. Children returning after 12 months
usually present with a new pain problem. Hence, we de-
fined the initial return visit to the treatment centre within a
12-months-period as the return visit under investigation.
Return visits after a 12-months-period were considered as
new referral and not included in the present analysis.
Data for the study were gathered retrospectively from
clinical letters at the initial appointment and at return-
visit. These letters included the pain diagnoses, treatment
recommendations and a summary of the diagnostic set of
questionnaires.
Measures
Average pain intensity was reported as average pain in-
tensity for the preceding four weeks on a numeric rating
scale (NRS; 0 = no pain to 10 =maximal pain).
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validated German Paediatric Pain Disability Index (P-PDI)
[16]. The questionnaire consists of 12 items (range 12–60)
and has good internal consistency (Cronbach’s alpha = .87)
and validity. It is used for children aged 11 years and above.
Parents reported the disability for children aged younger
than 11 years. We have previously found high agreement
between self and parental report on pain-related disability
(r = 0.624) [16].
School absence was assessed via parental report on the
number of days missed at school within the preceding 20
school days for schoolchildren aged 6 years and above. A
strong association has been shown between parental
reports of school absence and official school attendance
records [18]. Days of school missed were categorised into
three categories to enhance communication of results: low
(0–1 days missed), moderate (2–5 days missed), and high
school absences (more than 5 days missed). The categories
were derived from personal communication with the
Federal Ministry of Education and with teaching staff, be-
cause normative data for categorising the severity of
school absence is still lacking. These categories have been
previously used (e.g., [2]).
Statistical analyses
Group comparisons
Analysis A: Based on their completion of outpatient vs.
inpatient treatment, we subdivided the children into out-
patients and inpatients (see Flowchart Figure 1; Analysis
A) and compared their treatment outcome at the first
return visit to the treatment centre.
Analysis B: The second comparison of treatment out-
come at the first return to the treatment centre made
was between intensive inpatient treatment completers
and decliners. The latter were children who deliberately
refused intensive inpatient treatment but completed out-
patient treatment instead (Analysis B, Figure 1). Of im-
portance and in contrast to other health care systems, all
patients in Germany have equal access to all levels of
care. Hence, declining treatment was here framed as a
willing decision of the child and his/her family.
Statistical analysis for analysis A
Characteristics at the return visit were compared between
outpatients and inpatients regarding days until return,
sociodemographic characteristics, pain characteristics,
disability and school absence. We computed t-Tests for
independent samples, and Mann-Whitney U-test and
Chi2-statistics to compare outpatients and inpatients. The
effect sizes were computed and defined as follows: d for
t-test (>.2 = small effect, >.5 =moderate effect, >.8 = large
effect); r for U-test (>.1 = small; >.3 =medium; >.5 = large
effect); and Cramer’s V for Chi2 Test (>.1 = small effect;
>.3 =medium effect; >.5 = large effect) [19].Differences in changes in pain intensity and disability
between outpatients and inpatients
To explore individual changes in the metric outcome do-
mains (pain intensity, pain-related disability), we computed
standardised change scores by calculating the difference be-
tween the child’s scores at baseline and at follow-up and
dividing them by the standard deviation (SD) of the group’s
baseline score. Differences in these individual changes be-
tween inpatients and outpatients were calculated by an uni-
variate analysis of variances (ANOVA), using the group as
an independent variable (inpatients, outpatients) and the
respective change scores as the dependent variables. Next,
these differences were controlled for the influence of both
the initial scores on the respective outcome domain and of
the days until return (univariate analysis of covariances;
ANCOVA). We controlled for the initial scores because we
expected the inpatient group to report greater symptoms at
the initial session. Controlling for days until return was per-
formed because a longer time interval might be associated
with greater changes in outcome domains. The reported ef-
fect size for these analyses was partial eta2 (>.01 = small;
>.06 =medium; >.14 = large effect [19]). School absence
constituted an ordinal variable with three school absence
categories: low (0–1 day), moderate (2–5 days) and high
(>5 days).
Differences between outpatients vs. inpatients in clinically
significant changes in pain intensity and pain-related
disability
To investigate whether the obtained changes in pain inten-
sity and pain-related disability were equal, we determined
the number of outpatients and inpatients with clinically sig-
nificant changes in the two parameters, according to the
study by Jacobson and Truax [20]. They suggested two cri-
teria for a clinically relevant change: i) The magnitude of
change between pre- and post-treatment scores should be
statistically and reliably tested by use of a reliable change
index (RCI). This resulted in three outcome stages: “no reli-
able change”; “reliable deterioration”; or “reliable improve-
ment” for each patient and each parameter. ii) By the end
of the treatment, the patients should move from a dysfunc-
tional to a functional level to render them indistinguishable
from healthy people. Therefore, cut-off points for the two
parameters were defined. We adapted the procedure to de-
fine these cut-off points from prior publications [6,11]: For
P-PDI, a cut-off point of 23.09 (range: 12–60) was defined
based on a previous study into the effectiveness of inpatient
treatment [12]. For pain intensity, a raw-change of -1 on an
NRS was used [21]. Hirschfeld et al. [21] recently showed
within a group of 153 adolescents with severe chronic pain
that raw changes of -1 NRS point can be considered as a
minimally clinically significant difference. Using these cut-
off points together with the RCI, we defined children with
and without clinically significant changes in the two
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ber of outpatients vs. inpatients with clinically significant
changes in the two parameters.
Comparison of changes in school absence
Changes in school absence were depicted in a cross table to
investigate potential shifts from one school absence cat-
egory at the first visit to another school absence category at
the return visit. Differences between outpatients and inpa-
tients in the distribution of children in the school absence
categories were calculated separately for each of the three
school absence categories at the initial visit by the use of
Mann-Whitney U-tests.
Statistical analysis for analysis B
We depicted how many children followed the recom-
mendation of intensive inpatient treatment (completers)
and how many refused the intensive inpatient treatment
(decliners) but completed outpatient treatment instead
(Figure 1). Characteristics at the return visit were com-
pared between decliners and completers regarding days
until return, sociodemographic characteristics, pain
characteristics, disability and school absence, analogous
to Analysis A. The differences in individual changes in
pain intensity and pain-related disability, in clinically
significant changes in pain intensity and pain-related
disability, and in changes in the ordinal outcome of
school absences were computed according to the statis-
tical analyses described in Analysis A.
A two-tailed significance level of p = .05 was defined as
significant. All analyses were calculated using SPSS 21.
Results
Return pattern of the children
From July 2005 to June 2010, 2249 children with chronic
pain presented for treatment at the German Paediatric Pain
Centre (see Zernikow et al. [2] for a detailed depiction of the
sample). Of these children, 44 received inpatient treatment
on other wards of the Children’s Hospital prior to the initial
session at our institute and were excluded from further ana-
lyses. Of the remaining 2205 children, a total of 1312 chil-
dren attended a return visit within a 12-months-period,
including 992 outpatients and 320 inpatients (Figure 1). This
sample constitutes the sample for Analysis A.
There were n = 736 children who were recommended
inpatient treatment by the pain team. Additionally, n =
16 outpatients obtained inpatient treatment resulting in
a total sample of n = 512. Of these, n = 320 returned to
the treatment centre within 12 months. For Analysis B,
we compared n = 67 children who declined inpatient
treatment but pursued outpatient treatment instead to
n = 309 inpatient completers.
Children who returned for treatment did not differ from
those who did not return in age, sex, pain intensity or pain-related disability (p > .05). The two groups differed in the
rate of school absence (U= 420,750; Z= -2.2; p= .026;
r= |-.051|), showing higher rates of school absence in chil-
dren who did not return.Analysis A: outpatients vs. inpatients
Comparison of characteristics of outpatients and inpatients
at the time point of return
The characteristics of the two groups (inpatients, outpa-
tients) at time point of return are depicted in Table 1.
Inpatients returned significantly later compared to out-
patients. They were also significantly older and more
often female. The main pain locations also differed be-
tween the inpatients and outpatients. Headache was
highly predominant in the outpatient group, followed by
abdominal pain and musculoskeletal pain. In the in-
patient group, headache was also the most frequent
main pain location, but abdominal and musculoskeletal
pain had a higher prevalence compared to outpatients.
Pain intensity and pain-related disability did not differ
between the groups when the patients came for a return
visit. The average pain intensity was approximately four
in both groups. School absence at the return visit was
more frequent in former inpatients, with 22% reporting
moderate or high school absence within the preceding
four weeks compared to 16% of the outpatients.Differences in changes in pain intensity and disability
between outpatients and inpatients
At the return visit, children in both groups achieved mod-
erate to large changes in pain intensity (Table 2). The
greatest change was found for disability. Generally, change
scores at the return visit were larger in inpatients com-
pared to outpatients (all p < .01). When controlled for ini-
tial scores and days until return, the two groups differed
significantly in the change of pain-related disability. Spe-
cifically, inpatients reported greater changes in disability
compared to outpatients.Differences in clinically significant changes in pain intensity
and disability between outpatients and inpatients
More inpatients than outpatients achieved clinically
significant changes in pain intensity (Chi2(1) = 4.629;
p = .031; Cramer’s V = .061). Specifically, 52% (n = 162)
of the inpatients compared to 45% (n = 413) of the out-
patients achieved clinically significant changes in pain
intensity (Figure 2).
Similarly, more inpatients than outpatients achieved
clinically significant changes in pain-related disability
(46%, n = 135 vs. 31%, n = 265) (Chi2(1) = 21.649;
p < .001; Cramer’s V = .138).
Table 1 Characteristics at return visit (outpatient vs. inpatient)
Outpatients (n = 992) Inpatients (n = 320) Statistics
Mean SD Range n (%) Mean SD Range n (%) Parameter (t, Chi2) p-value Effect size§
Days until return visit 97.0 38.1 12–344 992 128.6 47.4 29–313 320 t(1310) = 12.117 <.001 d = 0.83
Age 11.0 3.3 1–19 992 13.9 2.5 5–19 320 t(1310) = 14.234 <.001 d = 0.88
Sex Chi2(1) = 14.125 <.001 V = .104
Male 421 (42) 98 (31)
Female 571 (58) 222 (69)
Main pain location Chi2(3) = 128.2 <.001 V = .313
Head 813 (82) 168 (53)
Abdomen 110 (11) 68 (21)
Musculoskeletal 63 (6) 71 (22)
Other 4 (0.4) 12 (4)
Average pain intensity$ 4.2 2.7 0–10 942 4.3 2.9 0–10 314 t(1254) = 0.546 .585 -
Pain-related disability# 24.8 10.7 12–60 894 23.9 10.0 12–60 298 t(1190) = -1.244 .214 -
School absence& 0–20 U = 184,632; Z = 12.2 <.001 r = .357
Low (0–1 day) 738 (84) 233 (78)
Moderate (2–5 days) 117 (13) 40 (13)
High (>5 days) 22 (3) 27 (9)
§Effect sizes for t-tests = d; for U-Tests = r; and for Chi2-test = Cramer’s V.
$Numeric rating scale (NRS) 0–10: 0 = no pain, 10 = worst pain.
#Paediatric Pain Disability Index (P-PDI [15], range 12–60).
&There were n = 66 children aged younger than six years for whom school absence could not be assessed.
Boldface data reflect significant differences between the two groups.
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outpatients and inpatients
Table 3 depicts the changes in school absence from the ini-
tial visit to the return visit for the outpatient and inpatient
groups.
The two groups differed in their changes in school ab-
sence within the group that reported moderate school ab-
sence at the initial visit (Figure 3). Inpatients achieved
greater changes.Analysis B: decliners of intensive inpatient treatment
vs. completers
Comparison of characteristics of decliners vs. completers
at the time point of return
The two groups did not differ regarding sex or main
pain location. Children in both groups were on average
13 years old (SDdecliners = 3.2; SDcompleters = 2.4). There
was a significant age difference between the two groups
(t(df = 374) = 1.99, p < .05) due to an outlying three years
of age in the group of inpatient decliners. The difference
disappeared when the outlier was excluded. Both groups
also reported comparable levels of pain intensity at the
return visit (Table 4). Decliners returned significantly
earlier compared to completers. Pain-related disability
was significantly higher in decliners, who also reported
moderate school absences more frequently.Differences in changes in pain intensity and disability
between decliners vs. completers
Completers achieved greater changes in pain-related dis-
ability compared to decliners. This holds true, even after
controlling for the initial score and time interval until
return (Table 5). The achieved large changes in pain in-
tensity were comparable between the two groups.Differences in clinically significant changes in pain intensity
and disability between decliners vs. completers
A similar amount of inpatient decliners and inpatient
completers, i.e. approximately half in each group (de-
cliners: n = 29, 46%; completers: n = 156, 52%) achieved
clinically significant changes in pain intensity (Chi2(1) =
0.621; p = .431) (Figure 2).
More completers than decliners achieved clinically sig-
nificant changes in pain-related disability. Specifically, there
were 47% (n = 132) of the completers compared to 25%
(n = 14) of the decliners with clinically significant changes
in pain-related disability (Chi2(1) = 9.056; p = .003; Cramer’s
V = .164).Differences in changes in school absence between decliners
vs. completers
The changes in school absence for decliners vs. com-
pleters are depicted in Table 6.
Table 2 Comparison of individual changes (pain intensity, pain-related disability) between inpatients and outpatients
Group Statistics for main effect “group”
Outpatients Inpatients ANOVA ANCOVA covariate: initial score + days until return
Individual changes§ Mean SD n Mean SD n df F p-value eta2 df F p-value eta2
Pain intensity$ 0.9 1.5 920 1.2 (1.5) 312 1,1230 10.5 .001 .008 1,1228 0.1 .728 -
Pain-related disability# 1.0 1.2 850 1.4 (1.2) 292 1,1140 33.2 <.001 .028 1,1138 12.6 <.001 .011
Note:
§Individual change: (Child’s score at baseline – child’s score at follow-up)/SD of the group baseline score; Interpretation of standardised change scores: 0.6 to 0.99
is considered a moderate change; ≥1.0, a large change.
$Numeric rating scale (NRS) 0–10.
#Paediatric Pain Disability Index (P-PDI [15]).
Boldface data reflect significant differences between the two groups.
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sences within the group with initially moderate school
absences (Figure 3). Completers with initially moderate
school absence achieved greater changes in school ab-
sence than decliners (U = 265; Z = -3.6; p < .001) with
more than 88% of the completers compared to 46% of
the decliners reporting low school absence.
The majority of both, decliners and completers, with
initially low school absence reported low school absence
at the return-visit (U = 742; Z = 0.179; p = .858). Similarly,
approximately 60% of both, decliners and completers withFigure 2 Comparison between outpatients vs. inpatients and betwee
in pain intensity and disability. The figure shows the number of children
left part of the figure (a) shows the comparison between outpatients and
and completers. Clinically significant changes were defined according to Ja
pre- and post-treatment scores, and ii) as patients’ move from a dysfunctio
raw change of -1 on an NRS [21]. Cut-off for disability was defined as a PPDinitially high school absence reported low school absence,
20% reported moderate and 16% reported high school ab-
sence at the return-visit (U = 1,1152; Z = -0,123; p = .902).
Discussion
The present study aimed to compare changes in three out-
come domains between children obtaining interdisciplinary
outpatient treatment and children obtaining intensive inter-
disciplinary inpatient treatment and between decliners and
completers of inpatient treatment. Overall, the results indi-
cate that both treatments are effective in improving painn decliners vs. completers regarding clinically significant changes
with clinically significant changes in pain intensity and disability. The
inpatients. The right part (b) shows the comparison between decliners
cobson and Truax as i) statistical and reliable change between
nal to a functional level. Cut-off for pain intensity was defined as a
I-score of 23.09 (range: 12–60) based on previous studies [12].
Table 3 Comparison of changes in school absence for inpatients and outpatients
Statistics
School absence at return visit Mann-Whitney U-Test
School absence& at initial visit Group Low (0–1 days) Moderate (2–5 days) High (>5 days) U Z p-value r
Low (0–1 days) Outpatients 454 (92.5) 34 (6.9) 3 (0.6) 17,792 -0.6 .524 -
Inpatients 70 (94.6) 3 (4.1) 1 (1.4)
Moderate (2–5 days) Outpatients 181 (71.3) 64 (25.2) 9 (3.5) 7,691 -2.7 .006 |-.151|
Inpatients 63 (87.5) 7 (9.7) 2 (2.8)
High (>5 days) Outpatients 69 (73.4) 16 (17.0) 9 (9.6) 6,988 1.8 .068 -
Inpatients 83 (62.4) 28 (21.1) 22 (16.5)
Notes: Frequencies are depicted as n (%).
&School absence is reported for children aged six years and older.
Boldface data reflect significant differences between the two groups.
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ous effectiveness studies [4,5,11,12]. The present results,
however, suggest that substantially greater changes can be
achieved via intensive inpatient treatment, in particular
with regards to pain-related disability and school absence.
In line with our hypothesis, children in intensive in-
patient treatment achieved greater changes in pain in-
tensity, pain-related disability and in school absence.
There were also significantly more inpatients with clinic-
ally significant changes in pain intensity (52% vs. 45%)Figure 3 Comparison between outpatients vs. inpatients and betwee
deterioration in school absence for the group of children with initiall
absence for children with initially moderate school absence (i.e., 2 to 5 day
comparison between outpatients vs. inpatients. The right part (b) shows th
assigned to the ‘Improvement-group’ if they reported low school absence
children who still reported moderate school absence (2 to 5 days/week) at
high school absence (>5 days/week) at the return-visit.and disability (46% vs. 31%). These results highlight the
potential of intensive interdisciplinary pain treatment to
achieve significant and clinically relevant improvements.
The change in school absence is particularly important.
First, results suggest that outpatient and inpatient treat-
ment enables children to maintain regular school attend-
ance. Second, results suggest that in both groups high
school absence can be substantially reduced as reflected
by an incidence of less than 10% of children with high
school absence at the return-visit in each group. Thisn decliners vs. completers regarding improvements, stable or
y moderate school absence. The figure shows changes in school
s within four school weeks). The left part of the figure (a) shows the
e comparison between decliners vs. completers. Children were
(<2 days/week) at the return visit. ‘Stable school absence’ represents
the return-visit and ‘deterioration’ represents children who reported






Mean SD Range n (%) Mean SD Range n (%) Parameter (t, Chi2) p-value Effect size§
Days until return visit 88.1 56.7 18–323 67 129.4 47.7 29–313 309 t(374) = 6.203 <.001 d = 0.79
Sex Chi2(1) = 0.22 .882 -
Male 21 (31) 94 (30)
Female 46 (69) 215 (70)
Main pain location Chi2(3) = 0.998 .802 -
Head 39 (59) 162 (53)
Abdomen 13 (20) 66 (21)
Musculoskeletal 12 (18) 68 (22)
Other 2 (3) 12 (4)
Average pain intensity$ 4.8 2.8 0–10 63 4.4 2.9 0–10 304 t(365) = -1.056 .834 -
Pain-related disability# 27.2 9.9 12–47 58 23.9 10.0 12–60 288 t(344) = -2.259 .024 d = 0.33
School absence& 0–20 U = 9,100; Z = 2.1 .032 r = .12
Low (0–1 day) 41 (71) 226 (78)
Moderate (2–5 days) 12 (21) 36 (13)
High (>5 days) 5 (9) 27 (9)
§Effect sizes for t-tests = d; for U-Tests = r; and for Chi2-test = Cramer’s V.
$Numeric rating scale (NRS) 0–10; 0 = no pain, 10 = worst pain.
#Paediatric Pain Disability Index (P-PDI, [15], range 12–60.
&School absence is reported for children aged six years and older.
Boldface data reflect significant differences between the two groups.
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http://www.biomedcentral.com/1471-2431/14/262also means that approximately half of the inpatient sam-
ple that initially reported high school absence is now
able to attend school. Third, for children who initially
reported moderate school absence (approximately 30%
in each group), results suggest that intensive interdiscip-
linary pain treatment can result in more pronounced de-
creases of school absence. Potential candidates for these
greater changes after intensive inpatient treatment can
be the treatment intensity, daily treatment with various
professionals, specific school-based interventions, such
as attending home-school during inpatient treatment [9]
and a more pronounced decline in pain-related fear dur-
ing intensive pain treatment [13].
Despite these positive findings, there was a group of less





Individual changes§ Mean SD n Mean SD n
Pain intensity$ 1.1 1.4 63 1.2 1.5 303
Pain-related disability# 0.9 1.0 56 1.4 1.2 282
Note:
§Individual change: (Child’s score at baseline – child’s score at follow-up)/SD of the
change; ≥1.0 large change.
$Numeric rating scale (NRS) 0–10.
#Paediatric Pain Disability Index (P-PDI, [15]).
Boldface data reflect significant differences between the two groups.inpatient treatment that maintained a high level of school
absence at return. This is in line with previous effective-
ness studies for intensive inpatient treatment, which
reported a percentage of approximately 10 to 20% with
negative treatment results [11]. For this particular group,
it is important to identify reasons for the stable high
school absence, such as stable emotional distress [11], and
to develop specific school-based interventions incorporat-
ing interventions to decrease emotional distress and
school absence [22].
Importantly, the ability to achieve greater changes in
pain intensity, disability and moderate school absences
via intensive inpatient treatment was also confirmed by
comparing decliners of inpatient treatment who com-
pleted outpatient treatment instead to completers.decliners vs. completers
Statistics for main effect group
ANOVA ANCOVA covariate: initial score + time
difference
df F p-value eta2 df F p-value eta2
1,364 0.3 .573 - 1,362 0.7 .420 -
1,336 11.8 .001 .034 1,334 5.7 .018 .017
group baseline score; Interpretation of change scores: 0.6 to 0.99: moderate
Table 6 Comparison of changes in school absence between decliners and completers
Statistics
School absences at return visit Mann-Whitney U-Test
School absences& at initial visit Low (0–1 days) Moderate (2–5 days) High (>5 days) U Z p-value r
Low (0–1 days) decliners 20 (95.2) 1 (4.8) 0 742 0.2 .858 -
completers 66 (94.3) 3 (4.3) 1 (1.4)
Moderate (2–5 days) decliners 6 (46.2) 6 (46.2) 1 (7.7) 265 -3.6** <.001 |-.395|
completers 62 (88.6) 6 (8.6) 2 (2.9)
High (>5 days) decliners 11 (61.1) 4 (22.2) 3 (16.7) 1252 -0.3 .902 -
completers 82 (63.1) 26 (20.0) 22 (16.9)
Note: Frequencies are depicted as n (%).
&School absence is reported for children aged six years and older.
Boldface data reflect significant differences between the two groups.
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by almost 50% in each group achieving clinically signifi-
cant changes in pain intensity, disability and approxi-
mately 70% rate of regular school attendance at the
return visit, regardless of their different therapeutic
choices. This finding may be indicative of additional fac-
tors influencing the decliners which may also relate to
self-selection of treatment, such as a higher treatment
motivation or higher family resources, which may coun-
teract their smaller therapeutic dose. Of importance and
in contrast to other health care systems, all patients in
Germany have equal access to all levels of care. Hence,
declining treatment was here framed as a willing deci-
sion of the child and his/her family. Results, however,
also indicate greater changes in disability and moderate
school absence in completers than decliners, in line with
our study hypothesis. This is also reflected by the
greater levels of disability and moderate school absence
in decliners at the return visit. A similar added value for
intensive interdisciplinary pain treatment has been
shown for adult patients with chronic low back pain
[23,24]. Although these studies implemented mono-
disciplinary treatment approaches, such as a muscle-
conditioning programme [23] or an outpatient active
physiotherapy [24] as a comparison group, they all
revealed a greater decrease in sick-leave days for
patients who obtained intensive interdisciplinary pain
treatment in accordance with the present study results.
Given that disability constitutes a prevailing maintaining
factor for chronic pain, its decrease is of utmost importance
and represents a number one priority treatment goal [7].
While evidence for decreases in disability via psychological
pain treatment remains scarce [25], the present study
indicates the potential of intensive inpatient treatment to
decrease disability in highly affected children. The above-
mentioned mechanism of intensive inpatient treatment
may account for the greater changes in the completers.Limitations
The present study has several limitations. This study
constitutes a naturalistic practice-based study without
randomisation and lacks a control group. Any findings
of significance can therefore only reflect a correlation
and not a causal relationship. In addition, the study de-
sign involved a comparison of two groups - outpatients
vs. inpatients - which were created among others based
on baseline pain and disability and subsequently com-
pared on change in these variables. This is a necessary
approach in a naturalistic study but entails the risk of a
regression-to-the-mean effect [26] and therefore a
greater likelihood to find statistically significant im-
provements in the more severely affected inpatient
group. One way to control for this effect is to compare
patients with similar levels of pain intensity and dis-
ability, as was done by the comparison of decliners to
completers in this study. An additional comparison of
outpatients and inpatients with a comparable high level
of pain intensity (of n = 84 outpatients and n = 52 in-
patients) also revealed a greater reduction in disability in
the inpatient-group (F(1,134) = 6.80, p = .010). Additional
ways to control for this effect which may be imple-
mented in future studies wherever feasible are a random
allocation to comparison groups [26].
Second, the described sample consisted of children
with severe chronic pain conditions referred to tertiary
treatment. Thus, any generalisation of these findings to
less affected children may be ill-advised. Generalizability
of the present findings may also be hampered due to the
fact that children in the present study self-selected
assignment to the two treatment options vs. treatment
assignment driven by insurance.
While we did depict the return patterns of the chil-
dren, assessment of the following variables was not feas-
ible due to the naturalistic design of the study and
warrants investigation in future studies: reasons for
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http://www.biomedcentral.com/1471-2431/14/262return to the treatment centre, reasons for denying inten-
sive inpatient treatment, what treatment modules were pur-
sued among the outpatient group and information on the
transition into outpatient services. Previous studies found
high rates of adherence for physical therapy and moderate
adherence to begin cognitive-behavioural therapy [27].
The present outpatient treatment is of low dose. This low
treatment dose at a specialized treatment centre might
increase access to specialized care compared to treatments
with frequent appointments. There is still a scarcity of
specialized treatment centres worldwide [28] resulting in
distance barriers and travel burdens for the child
and his/her family [29].
Future studies are warranted comparing inpatient pro-
grams to outpatient programs that differ in length and
treatment dose, into how the treatment dose might re-
late to treatment access of affected children, and into
adherence to treatment recommendations, particularly
for psychological interventions, e.g. by increasing educa-
tional efforts [27].
Conclusion
Interdisciplinary outpatient treatment and intensive in-
patient treatment are two effective forms of treatment
for paediatric chronic pain that differ in their thera-
peutic conception and treatment intensity. Here, we
replicated the effectiveness of both treatments in terms
of substantial improvements in functioning and school
absence within a naturalistic practice-based longitudinal
study. The findings also highlight the importance of
allocating children appropriately to outpatient vs. in-
patient treatment. Children who denied intensive in-
patient treatment and completed outpatient treatment
instead achieved less improvement and were more
disabled at the return visit than were the children who
completed the intensive inpatient treatment. The inten-
sive treatment also elicits greater changes in pain inten-
sity, disability and moderate school absences, which are
necessary factors for consideration among severely
affected children with chronic pain. It is therefore highly
relevant to enhance motivation for intensive inpatient
treatment when necessary and to overcome potential
barriers of children and their families. Future research is
warranted into the mechanisms of change in both forms
of treatment [30], into other assessment tools facilitat-
ing the allocation to the two forms of treatment [10],
into therapeutic strategies to enhance the motivation
for intensive inpatient treatment, and into comparisons
between inpatient programs versus outpatient programs
that differ in length and treatment dose, and how this
might relate to treatment access.
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